FDA Inspection 1034770 — Ingenus Pharmaceuticals GmbH

Ingenus Pharmaceuticals GmbH — FEI 3005403232

The FDA completed an inspection of Ingenus Pharmaceuticals GmbH on Oct 31, 2017 in Barbengo. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 31, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Barbengo (Switzerland)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.